Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

Summary

Ascletis Pharma announced that its ordinary shares have been included in the Hong Kong Stock Connect List under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs, expanding accessibility to mainland Chinese investors.